SA PRO
Free Account
IDEXX Laboratories, Inc.IDXXNASDAQ
LOADING
|||
OverviewNewsChartFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 59% recommend buying.

Consensus Rating
Buy
22 analysts·High coverage
59%
Rating Distribution
Strong Buy
00%
Buy
1359%
Hold
836%
Sell
15%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Dec 8, 2025Barclays
Idexx Laboratories initiated with an Overweight at Barclays
Target:$850.00
+20.3%from $706.65
Nov 4, 2025Morgan Stanley
Idexx Laboratories price target raised to $805 from $765 at Morgan Stanley
Target:$805.00
+11.6%from $721.04
Nov 4, 2025UBS
Idexx Laboratories price target raised to $750 from $710 at UBS
Target:$750.00
+3.7%from $722.94
Nov 4, 2025BTIG
Idexx Laboratories price target raised to $830 from $785 at BTIG
Target:$830.00
+14.8%from $722.94
Nov 4, 2025Jefferies
IDEXX Laboratories (IDXX) PT Raised to $830 at Jefferies
Target:$830.00
+14.8%from $722.94
Nov 3, 2025Leerink Partners
Idexx Laboratories price target raised to $785 from $745 at Leerink
Target:$785.00
+8.6%from $722.94
Nov 3, 2025Stifel Nicolaus
IDEXX Laboratories (IDXX) PT Raised to $775 at Stifel
Target:$775.00
+7.2%from $722.94
Oct 31, 2025Stifel Nicolaus
Stifel Upgrades IDEXX Laboratories (IDXX) to Buy
Target:$700.00
+11.4%from $628.54
Oct 1, 2025UBS
Idexx Laboratories initiated with a Neutral at UBS
Target:$720.00
+12.7%from $638.89
Aug 5, 2025Morgan Stanley
Idexx Laboratories price target raised to $722 from $626 at Morgan Stanley
Target:$722.00
+12.5%from $641.94
Aug 5, 2025BTIG
Idexx Laboratories price target raised to $785 from $545 at BTIG
Target:$785.00
+22.3%from $641.94
Aug 4, 2025Stifel Nicolaus
Idexx Laboratories price target raised to $640 from $540 at Stifel
Target:$640.00
-6.3%from $682.78
Jun 24, 2024Stifel Nicolaus
Idexx Laboratories price target lowered to $510 from $520 at Stifel
Target:$510.00
+2.9%from $495.73
Feb 8, 2023Barclays
Barclays Maintains Overweight on IDEXX Laboratories, Raises Price Target to $590
Target:$590.00
+16.2%from $507.68
Feb 7, 2023J.P. Morgan
JP Morgan Maintains Overweight on IDEXX Laboratories, Raises Price Target to $550
Target:$550.00
+12.9%from $487.04
Feb 7, 2023Atlantic Equities
Atlantic Equities Maintains Overweight on IDEXX Laboratories, Raises Price Target to $600
Target:$600.00
+23.6%from $485.53
Feb 2, 2023Oppenheimer
Oppenheimer Maintains Outperform on IDEX, Raises Price Target to $247
Target:$247.00
-48.9%from $483.20
Feb 2, 2023Citigroup
Citigroup Maintains Buy on IDEX, Lowers Price Target to $268
Target:$268.00
-44.5%from $483.20
Dec 9, 2022Citigroup
Citigroup Maintains Buy on IDEX, Raises Price Target to $273
Target:$273.00
-35.1%from $420.63
Nov 15, 2022Morgan Stanley
Morgan Stanley Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $543
Target:$543.00
+24.6%from $435.78
Jun 24, 2022Stifel Nicolaus
Stifel Maintains Buy on IDEXX Laboratories, Lowers Price Target to $500
Target:$500.00
+40.6%from $355.62
May 19, 2022Goldman Sachs
Goldman Sachs Maintains Neutral on IDEXX Laboratories, Lowers Price Target to $530
Target:$530.00
+48.3%from $357.33
May 6, 2022Barclays
IDEXX Laboratories (IDXX) Stock: $700 Price Target And Overweight Rating
Target:$700.00
+92.0%from $364.50

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance